Biodesix (BDSX) Depreciation & Amortization (CF) (2019 - 2026)

Biodesix has reported Depreciation & Amortization (CF) for 8 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 3.06% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (down 2.92% YoY), and the FY2025 full-year result was $5.7 million, down 1.78% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $1.4 million, up from $1.4 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $1.5 million in Q3 2024, with the low at $782000.0 in Q3 2023.
• Historically, Depreciation & Amortization (CF) has averaged $1.2 million across 5 years, with a median of $1.4 million in 2025.
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) retreated 13.55% — and 2024, when it surged 90.92%.
• Biodesix's Depreciation & Amortization (CF) stood at $898000.0 in 2022, then rose by 8.8% to $977000.0 in 2023, then jumped by 48.31% to $1.4 million in 2024, then dropped by 4.28% to $1.4 million in 2025, then gained by 0.65% to $1.4 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.